CJC1295 without DAC

CJC-1295 without DAC is a synthetic peptide, produced via solid-phase peptide synthesis for research applications. Researchers consider CJC-1295 without DAC to be a potent growth hormone-releasing hormone receptor (GHRHR) agonist with a unique profile of biological activities that extend across multiple physiological systems.(2) The peptide is posited to function through selective receptor activation on somatotroph cells in the anterior pituitary, initiating signaling cascades that culminate in growth hormone secretion. Unlike its DAC-containing counterpart which provides sustained hormone elevation, CJC-1295 without DAC demonstrates a plasma half-life of approximately 30 minutes, similar to native GHRH, which may contribute to more physiological pulsatile secretion patterns.

The mechanism by which CJC-1295 without DAC may potentially stimulate growth hormone release appears to involve complex interactions with G-protein coupled receptor signaling pathways. The peptide is considered to bind to GHRHR on pituitary somatotrophs, activating adenylyl cyclase and increasing intracellular cyclic AMP (cAMP) levels, ultimately leading to calcium-mediated exocytosis of growth hormone-containing secretory granules. Additionally, CJC-1295 without DAC may indirectly influence insulin-like growth factor-1 (IGF-1) production through growth hormone-mediated effects on hepatic tissue. This action may result in downstream anabolic and metabolic effects that have been observed across various research models.

CJC-1295 without DAC's biological activities are considered to extend across numerous physiological systems, suggesting a fundamental role in growth, metabolism, and tissue homeostasis. The mechanism by which CJC-1295 without DAC may potentially influence these diverse processes appears to involve both direct growth hormone-mediated effects and indirect effects through IGF-1 and other downstream mediators. These alterations in neuroendocrine signaling and metabolic processes may impact various physiological parameters, which are considered to be critical factors in numerous biological processes related to protein synthesis, lipolysis, tissue repair, and metabolic regulation.

Chemical Makeup

Molecular Formula: C152H252N44O42

Molecular Weight: 3367.2 g/mol

Sequence: Modified GHRH (1-29) with substitutions at positions 2, 8, 15, and 27

Other Known Titles: Modified GRF 1-29, Mod GRF 1-29, CJC-1295 no DAC

Research and Clinical Studies

CJC-1295 Without DAC and Growth Hormone Secretion Dynamics

Research has been undertaken to evaluate the potential actions of CJC-1295 without DAC on growth hormone secretion patterns and neuroendocrine regulation in various experimental models. One study aimed to assess the peptide's role in promoting pulsatile growth hormone release, focusing on its potential to enhance physiological secretion patterns through GHRHR activation.(3) More specifically, researchers posited that CJC-1295 without DAC may provide more natural hormone release kinetics compared to long-acting analogs and may promote episodic growth hormone elevation that more closely mimics endogenous secretion dynamics.

The study suggests that CJC-1295 without DAC may promote improvements in growth hormone secretion patterns in research models through multiple mechanisms. It is posited that CJC-1295 without DAC may bind selectively to growth hormone-releasing hormone receptors on pituitary somatotrophs, potentially initiating cAMP-mediated signaling cascades. The peptide may also enhance the amplitude of growth hormone pulses without significantly extending pulse duration. These activities suggest that the peptide might facilitate more physiological hormone secretion patterns. The mechanism appears to involve both enhanced receptor activation and the peptide's shorter half-life of approximately 30 minutes, which allows for pulsatile rather than sustained hormone elevation.

Moreover, it is mentioned that CJC-1295 without DAC has been studied in various contexts of growth hormone physiology and has been evaluated for its potential to stimulate episodic growth hormone release that follows circadian patterns. The peptide's structural modifications—including substitutions at positions 2, 8, 15, and 27—are considered particularly relevant for enhancing resistance to dipeptidyl aminopeptidase-IV (DPP-IV) degradation while maintaining receptor specificity. CJC-1295 without DAC may also influence the relationship between pulse frequency and amplitude in growth hormone secretion. Studies suggest that further research is needed to fully understand the peptide's mechanisms of action in regulating pulsatile hormone dynamics and its potential applicability in various neuroendocrine research contexts.

CJC-1295 Without DAC and Anabolic Signaling

Studies have explored various mechanisms via which CJC-1295 without DAC may influence anabolic processes and protein synthesis in skeletal muscle and other tissues.(4) One proposed mechanism suggests that CJC-1295 without DAC may enhance growth hormone secretion, which subsequently stimulates hepatic IGF-1 production through growth hormone receptor activation and JAK-STAT signaling pathways. The improvements in anabolic signaling observed in research models in the presence of CJC-1295 without DAC may be mediated by enhanced mTOR (mechanistic target of rapamycin) pathway activation, increased rates of protein accretion, and improved nitrogen retention.

The peptide's effects on anabolic signaling appear to involve modulation of multiple growth factor pathways, particularly those relevant to muscle tissue maintenance and growth. CJC-1295 without DAC may influence the expression of genes involved in protein synthesis and may affect the balance between protein synthesis and degradation. Studies have investigated the peptide's potential to promote muscle protein synthesis through both growth hormone-dependent and IGF-1-dependent mechanisms. The enhanced cellular activity and anabolic signaling might contribute to muscle tissue preservation and potential growth in research models.

Additionally, the peptide's episodic nature of growth hormone stimulation may be particularly relevant for optimizing anabolic responses, as research suggests that pulsatile hormone patterns may be more effective than continuous exposure for stimulating protein synthesis while avoiding receptor desensitization. By promoting episodic rather than sustained growth hormone elevation, CJC-1295 without DAC might optimize anabolic signaling cascades. Furthermore, the possibility that CJC-1295 without DAC may influence amino acid transport mechanisms and cellular energy metabolism has been investigated. The modulation of these pathways might enhance both the efficiency and magnitude of protein synthesis in research models. Studies have also examined whether CJC-1295 without DAC might affect satellite cell activation or influence the regenerative capacity of skeletal muscle tissue.

CJC-1295 Without DAC and Lipolysis

Research has investigated the potential effects of CJC-1295 without DAC on lipid metabolism and body composition in experimental models. Studies posit that CJC-1295 without DAC might influence lipolysis through mechanisms related to growth hormone's effects on adipose tissue metabolism.(5) Preliminary data tentatively suggests that CJC-1295 without DAC might potentially enhance fat mobilization and oxidation through activation of hormone-sensitive lipase and inhibition of lipoprotein lipase activity.

In elaborating on these pathways, growth hormone is known to exert significant effects on adipocyte metabolism, promoting the breakdown of triglycerides into free fatty acids and glycerol. CJC-1295 without DAC's ability to stimulate pulsatile growth hormone release may influence these lipolytic processes. The peptide may enhance substrate utilization patterns, potentially favoring fatty acid oxidation while preserving glucose and protein stores. Studies have suggested that CJC-1295 without DAC might affect the redistribution of body fat, particularly visceral adipose tissue, which has implications for metabolic health in research models.

The mechanism by which CJC-1295 without DAC may affect lipid metabolism appears to involve both direct growth hormone-mediated effects on adipocytes and indirect effects through changes in insulin sensitivity and glucose metabolism. Research has indicated that growth hormone can influence the expression of genes involved in lipid metabolism and may affect mitochondrial function in adipose tissue. The peptide may also influence energy expenditure and resting metabolic rate. Additionally, some studies have investigated whether CJC-1295 without DAC might affect the balance between fat storage and mobilization under various nutritional and metabolic conditions. These observations suggest that CJC-1295 without DAC may possibly play a role in metabolic regulation and body composition, although the precise mechanisms and magnitude of effects continue to be areas of active investigation.

CJC-1295 Without DAC and Recovery Processes

The peptide CJC-1295 without DAC may have roles in promoting tissue recovery and repair processes, based on investigations into its effects on various regenerative mechanisms. It is thought that CJC-1295 without DAC might facilitate recovery through multiple mechanisms, including enhancement of protein synthesis, promotion of cellular proliferation, and modulation of inflammatory responses following tissue stress or injury.(6) These processes are considered to potentially involve regulation of growth factor expression, enhancement of collagen synthesis, and optimization of tissue remodeling.

Research has suggested that CJC-1295 without DAC might particularly contribute to recovery from exercise-induced muscle damage and other forms of tissue stress. Studies have indicated that CJC-1295 without DAC may possibly enhance the regeneration of damaged tissues and may support the maintenance of tissue integrity during periods of metabolic stress. The peptide may influence the activity of various cell types involved in tissue repair, including fibroblasts, satellite cells, and immune cells. Researchers consider these observations as potential indicators of CJC-1295 without DAC's role in promoting functional recovery.

It is posited that by promoting both the anabolic aspects of tissue repair and the resolution of inflammatory processes, CJC-1295 without DAC might influence the quality and speed of recovery. This may involve optimization of nutrient delivery to tissues through enhanced vascularity, enhancement of cellular energy metabolism, and proper balance between tissue breakdown and synthesis. The peptide's potential effects on reducing recovery time following physical stress may be particularly important for research examining tissue adaptation and resilience. Given the importance of recovery processes in maintaining tissue health and function, CJC-1295 without DAC's potential to support recovery mechanisms has significant research interest. These potential effects on tissue recovery are still under investigation and hold promise for applications in various contexts of tissue stress and adaptation.

CJC-1295 Without DAC and Sleep Quality

Studies have explored the potential effects of CJC-1295 without DAC on sleep architecture and sleep quality in experimental models. Research suggests that CJC-1295 without DAC may influence sleep parameters through its effects on growth hormone secretion patterns, which exhibit strong circadian rhythmicity.(7) One proposed mechanism involves the relationship between growth hormone pulses and slow-wave sleep, with the majority of daily growth hormone secretion occurring during early sleep periods.

Investigations have indicated that CJC-1295 without DAC might potentially affect various aspects of sleep quality, including sleep depth, sleep efficiency, and the duration of restorative sleep stages. The peptide's effects appear to involve modulation of factors that regulate sleep architecture, including potential effects on sleep-promoting neurotransmitters and the timing of growth hormone pulses. CJC-1295 without DAC may influence the reciprocal relationship between growth hormone secretion and slow-wave sleep, where growth hormone promotes deeper sleep stages while deep sleep enhances growth hormone release.

The mechanism by which CJC-1295 without DAC may affect sleep quality appears to involve both direct effects on neuroendocrine regulation and indirect effects through the physiological consequences of enhanced growth hormone secretion. Research has indicated that adequate slow-wave sleep is critical for physical recovery, cognitive function, and metabolic health. Some studies have investigated whether CJC-1295 without DAC might have implications for recovery from sleep deprivation or might affect the restorative aspects of sleep. These potential effects on sleep quality continue to be investigated, with researchers examining the mechanisms by which growth hormone-releasing peptides might influence sleep architecture and the potential implications for various aspects of health and recovery.

CJC-1295 Without DAC and Bone Density

Research has investigated the potential effects of CJC-1295 without DAC on bone metabolism and skeletal health in various experimental models. Studies posit that CJC-1295 without DAC might influence bone health through mechanisms related to growth hormone and IGF-1 effects on bone-forming and bone-resorbing cells.(8) Preliminary data tentatively suggests that CJC-1295 without DAC might potentially enhance bone formation and affect bone remodeling dynamics.

In elaborating on these pathways, growth hormone and IGF-1 are known to play important roles in skeletal development and maintenance throughout life. CJC-1295 without DAC's ability to stimulate growth hormone secretion may influence osteoblast activity, the cells responsible for new bone formation. The peptide may also affect the differentiation of mesenchymal stem cells toward osteoblastic lineages and may influence the production of bone matrix proteins. Studies have suggested that CJC-1295 without DAC might affect both cortical and trabecular bone properties in research models.

The mechanism by which CJC-1295 without DAC may affect bone metabolism appears to involve both direct effects of growth hormone and IGF-1 on bone cells and indirect effects through changes in calcium metabolism and vitamin D regulation. Research has indicated that growth hormone can influence the expression of genes involved in bone remodeling and may affect the coupling between bone formation and bone resorption. The peptide's pulsatile growth hormone stimulation pattern may be particularly relevant for maintaining healthy bone remodeling dynamics. Some studies have investigated whether CJC-1295 without DAC might have implications for age-related bone loss or might affect bone healing processes. These observations suggest that CJC-1295 without DAC may possibly play a role in skeletal health, although the precise mechanisms and clinical significance continue to be areas of active research.

CJC-1295 Without DAC and Cognitive Function

Studies have explored the potential effects of CJC-1295 without DAC on cognitive processes and neurological function. Research suggests that CJC-1295 without DAC may influence cognitive parameters through growth hormone and IGF-1 effects on neural tissue.(9) One proposed mechanism involves these hormones' roles in neuroplasticity, neurogenesis, and neuroprotection in experimental systems.

Investigations have indicated that CJC-1295 without DAC might potentially affect various aspects of cognitive function, including memory consolidation, learning capacity, and processing speed. The peptide's effects appear to involve modulation of factors that support neuronal health and function, including potential effects on brain-derived neurotrophic factor (BDNF) expression and synaptic plasticity. CJC-1295 without DAC may influence hippocampal function, a brain region critical for memory formation and spatial navigation.

The mechanism by which CJC-1295 without DAC may affect cognitive function appears to involve both direct effects of growth hormone and IGF-1 on neural tissue and indirect effects through improved cerebral blood flow and metabolic support. Research has indicated that growth hormone receptors are expressed in various brain regions, including areas involved in memory and cognition. Some studies have investigated whether CJC-1295 without DAC might have implications for age-related cognitive decline or might affect recovery from neurological stress. Additionally, there is research interest in the peptide's potential effects on mood regulation and stress response systems. These potential effects on cognitive function continue to be investigated, with researchers examining the mechanisms by which growth hormone-releasing peptides might influence brain health and cognitive performance.

CJC-1295 Without DAC and Cardiovascular Health

The peptide CJC-1295 without DAC may have significant roles in cardiovascular function, based on investigations into its effects on cardiac and vascular physiology. It is thought that CJC-1295 without DAC might influence cardiovascular parameters through multiple mechanisms, including effects on cardiac contractility, vascular function, and endothelial health.(10) These processes are considered to potentially involve regulation of nitric oxide production, modulation of calcium handling in cardiac myocytes, and effects on vascular smooth muscle tone.

Research has suggested that CJC-1295 without DAC might particularly contribute to cardiovascular health through growth hormone's effects on cardiac structure and function. Studies have indicated that growth hormone may influence left ventricular mass, cardiac output, and exercise capacity in research models. The peptide may enhance endothelial function, which plays crucial roles in regulating blood flow, maintaining vascular tone, and preventing thrombosis. Researchers consider these observations as potential indicators of CJC-1295 without DAC's role in supporting cardiovascular health.

It is posited that by promoting both structural and functional aspects of cardiovascular performance, CJC-1295 without DAC might influence the heart's ability to adapt to physiological demands. This may involve optimization of myocardial energy metabolism, enhancement of coronary blood flow, and proper balance between cardiac workload and capacity. The peptide's potential effects on vascular compliance and blood pressure regulation may be particularly important for maintaining cardiovascular homeostasis. Some research has investigated whether CJC-1295 without DAC might affect recovery of cardiac function following injury or stress. Given the critical importance of cardiovascular health for overall physiological function, CJC-1295 without DAC's potential cardiovascular effects are of significant research interest. These potential effects on cardiovascular function are still under investigation and hold promise for understanding the peptide's role in cardiovascular physiology.

CJC-1295 Without DAC and Immune Function

Studies have explored the potential effects of CJC-1295 without DAC on immune system function and immunological parameters. Research suggests that CJC-1295 without DAC may influence immune responses through growth hormone's effects on various immune cells and thymic tissue.(11) One proposed mechanism involves growth hormone receptors expressed on lymphocytes, macrophages, and other immune cells, through which growth hormone may modulate immune cell development, proliferation, and function.

Investigations have indicated that CJC-1295 without DAC might potentially affect both innate and adaptive immune responses. The peptide's effects appear to involve modulation of cytokine production, enhancement of immune cell function, and potential effects on thymic regeneration. CJC-1295 without DAC may influence T-cell development and maturation, which are critical processes for maintaining a competent adaptive immune system. The peptide may also affect the function of natural killer cells and other components of the innate immune system.

The mechanism by which CJC-1295 without DAC may affect immune function appears to involve both direct growth hormone-mediated effects on immune cells and indirect effects through IGF-1 and other immune-modulating factors. Research has indicated that growth hormone can influence the expression of genes involved in immune cell activation and proliferation. Some studies have investigated whether CJC-1295 without DAC might have implications for immune competence during aging or stress, as growth hormone levels naturally decline with age. These potential effects on immune function continue to be investigated, with researchers examining the mechanisms by which growth hormone-releasing peptides might influence immunological health and the potential implications for resistance to infection and immune system resilience.

CJC-1295 Without DAC and Skin Health

Research has investigated the potential effects of CJC-1295 without DAC on skin physiology and dermal health in experimental models. Studies posit that CJC-1295 without DAC might influence skin properties through mechanisms related to growth hormone and IGF-1 effects on dermal fibroblasts, collagen production, and skin cell proliferation.(12) Preliminary data tentatively suggests that CJC-1295 without DAC might potentially affect skin thickness, elasticity, and wound healing capacity.

In elaborating on these pathways, growth hormone and IGF-1 are known to influence various aspects of skin biology, including the production of structural proteins, cellular turnover rates, and skin hydration. CJC-1295 without DAC's ability to stimulate growth hormone secretion may influence dermal collagen and elastin synthesis, proteins that provide structural support and elasticity to skin tissue. The peptide may also affect sebaceous gland function and epidermal cell proliferation. Studies have suggested that CJC-1295 without DAC might influence the skin's response to injury and its capacity for repair in research models.

The mechanism by which CJC-1295 without DAC may affect skin health appears to involve both direct effects of growth hormone and IGF-1 on skin cells and indirect effects through enhanced protein synthesis and tissue remodeling. Research has indicated that growth hormone can influence the expression of genes involved in extracellular matrix production and may affect the balance between collagen synthesis and degradation. The peptide may also influence skin vascularity, which is important for nutrient delivery and waste removal. Some studies have investigated whether CJC-1295 without DAC might have implications for age-related changes in skin structure and function or might affect the healing of dermal wounds. These observations suggest that CJC-1295 without DAC may possibly play a role in skin physiology and health, although the precise mechanisms and extent of effects continue to be areas of active investigation.

CJC-1295 without DAC peptide is available for research and laboratory purposes only. Please review our Terms and Conditions before ordering.